On May 11, 2022, AbbVie Inc announced that at its annual general meeting of shareholders held on May 6, 2022, a shareholder proposal relating to issue a report on board oversight of competition practices, was not approved.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
163.8 USD | +1.85% | +2.61% | +5.69% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.69% | 290B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B | |
+8.08% | 167B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Declaration of Voting Results by AbbVie Inc